A case of pulmonary toxicity associated with G-CSF and doxorubicin administration

 The cytokine growth factor, G-CSF (granulocyte colony-stimulating factor), is commonly used in oncologic practice and is generally believed to be a safe agent to administer. We describe here a case of pulmonary toxicity associated with the concurrent administration of G-CSF and doxorubicin. We cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenbeis, C. F., Winn, D., Poelman, S., Polsky, C. V., Rubenstein, J. H., Olopade, O. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2001
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101872/
https://www.ncbi.nlm.nih.gov/pubmed/11261324
http://dx.doi.org/10.1007/s002770000232
_version_ 1783511711972589568
author Eisenbeis, C. F.
Winn, D.
Poelman, S.
Polsky, C. V.
Rubenstein, J. H.
Olopade, O. I.
author_facet Eisenbeis, C. F.
Winn, D.
Poelman, S.
Polsky, C. V.
Rubenstein, J. H.
Olopade, O. I.
author_sort Eisenbeis, C. F.
collection PubMed
description  The cytokine growth factor, G-CSF (granulocyte colony-stimulating factor), is commonly used in oncologic practice and is generally believed to be a safe agent to administer. We describe here a case of pulmonary toxicity associated with the concurrent administration of G-CSF and doxorubicin. We contend that G-CSF contributed to the life-threatening lung injury in our patient, and discuss additional reports in the literature of pulmonary toxicity associated with the use of this agent.
format Online
Article
Text
id pubmed-7101872
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-71018722020-03-31 A case of pulmonary toxicity associated with G-CSF and doxorubicin administration Eisenbeis, C. F. Winn, D. Poelman, S. Polsky, C. V. Rubenstein, J. H. Olopade, O. I. Ann Hematol Case Report  The cytokine growth factor, G-CSF (granulocyte colony-stimulating factor), is commonly used in oncologic practice and is generally believed to be a safe agent to administer. We describe here a case of pulmonary toxicity associated with the concurrent administration of G-CSF and doxorubicin. We contend that G-CSF contributed to the life-threatening lung injury in our patient, and discuss additional reports in the literature of pulmonary toxicity associated with the use of this agent. Springer-Verlag 2001 /pmc/articles/PMC7101872/ /pubmed/11261324 http://dx.doi.org/10.1007/s002770000232 Text en © Springer-Verlag Berlin Heidelberg 2001 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Eisenbeis, C. F.
Winn, D.
Poelman, S.
Polsky, C. V.
Rubenstein, J. H.
Olopade, O. I.
A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
title A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
title_full A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
title_fullStr A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
title_full_unstemmed A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
title_short A case of pulmonary toxicity associated with G-CSF and doxorubicin administration
title_sort case of pulmonary toxicity associated with g-csf and doxorubicin administration
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101872/
https://www.ncbi.nlm.nih.gov/pubmed/11261324
http://dx.doi.org/10.1007/s002770000232
work_keys_str_mv AT eisenbeiscf acaseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT winnd acaseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT poelmans acaseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT polskycv acaseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT rubensteinjh acaseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT olopadeoi acaseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT eisenbeiscf caseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT winnd caseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT poelmans caseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT polskycv caseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT rubensteinjh caseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration
AT olopadeoi caseofpulmonarytoxicityassociatedwithgcsfanddoxorubicinadministration

Ejemplares similares